Viking Therapeutics (1VT.STU) Q2 2026 Earnings

29AprConfirmed
Q1 2026
Next
-1.16
-1.02
-0.89
-0.75

Details

Expected EPS
-0.8320687703999999
Actual EPS
N/A
Surprise EPS
0.83
Surprise Percent
+100%

Description

Viking Therapeutics (1VT.STU) will report earnings of for Q2 2026 on April 29, 2026.

0 Comments

Share your thoughts